Loading clinical trials...
Loading clinical trials...
Intravitreal injection of Bevacizumab in patients with Neovascular Membranes secondary to intraocular inflammation. We injected a single injection of Bevacizumab (2.5 mg/0.1 ml) and evaluate visual ac...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Asociación para Evitar la Ceguera en México
NCT03399175 · Vogt Koyanagi Harada Disease
NCT05496530 · Diabetic Macular Edema, Vogt Koyanagi Harada Disease, and more
NCT05120687 · Vogt Koyanagi Harada Disease (VKH)
Asociacion para Evitar la Ceguera en Mexico
Mexico City, Mexico City
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions